EQUINE RHINPNEUMONIA VIRUS (EQUINE HERPESVIRUS IV)REAL-TIME
Ausverkauft

EQUINE RHINPNEUMONIA VIRUS (EQUINE HERPESVIRUS IV)REAL-TIME

Verkaufspreis 1,147.81 د.إ.
Zur Wunschliste

Benachrichtigen, wenn wieder auf Lager

Geben Sie Ihre E-Mail-Adresse ein, um benachrichtigt zu werden, wenn das Produkt wieder verfügbar ist.

Guaranteed safe payment

EQUINE RHINOPNEUMONIA VIRUS (EQUINE HERPESVIRUS IV) REAL‑TIME
This product is a real-time PCR test kit designed to detect Equine Herpesvirus Type 4 (EHV‑4), also known as Equine Rhinopneumonia Virus, in horse samples. It enables rapid and accurate detection of the virus's DNA, supporting immediate intervention in cases of equine respiratory diseases.

Main Benefits


Rapid and accurate detection of EHV‑4 DNA in horse samples
Includes internal control to monitor extraction and amplification performance
Offers dual or multiplex formats for efficient testing
Compatible with a wide range of real-time PCR devices
Validated with clinical samples to ensure reliable results
Available in multiple reaction sizes (e.g., 50 or 100 reactions)

Composition


Primer and probe mix targeting EHV‑4 DNA
Internal control mix (in dual format kits)
Real-time PCR mastermix solution
Positive control template for test validation
Reconstitution solution and nuclease-free water (depending on kit type)

Instructions for Use


Use with horse samples such as nasal swabs, blood, or respiratory tissues
Conduct real-time PCR testing using the provided reagents and controls in a single-tube or multiplex format
Include internal control to detect any PCR inhibition or extraction failure
Quantification may be possible using the positive control, depending on kit design
A veterinarian or certified lab specialist should determine the dosage and cycle parameters based on sample type and clinical context

Package Size


Available in formats such as 50 reactions or 100 reactions, depending on the specified kit type

Note


Intended for veterinary use under professional supervision. This product supports rapid detection of EHV‑4 to aid in managing outbreaks of equine respiratory diseases.